DIFFERENT FREQUENCIES OF ANGIOTENSIN-CONVERTING ENZYME GENOTYPES IN OLDER HYPERTENSIVE INDIVIDUALS

被引:130
|
作者
MORRIS, BJ
ZEE, RYL
SCHRADER, AP
机构
[1] Department of Physiology, School of Medicine, University of Sydney
[2] School of Medicine, Building F13, University of Sydney
关键词
CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; SURVIVAL;
D O I
10.1172/JCI117423
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The frequency of the D allele of an insertion/deletion (I/D) polymorphism of the angiotensin I-converting enzyme (ACE) gene has been reported to be elevated in myocardial infarction and other patients. We therefore hypothesized that death rate of DD individuals should be increased in the population as a whole and this should be evident as a decrease in DD frequency with age. This hypothesis was tested in 118 Caucasian subjects who were already at high risk of cardiovascular events by having severe, early onset, familiar hypertension (HT). A group of 196 age-, sex- and body mass index-matched normotensives (NTs) was used as a control. In the NT group II, ID, and DD genotype frequencies were similar for different age groups. DD frequency was 0.42 in NTs, but in HTs was 0.28, 0.26, and 0.10 for the age groups < 50, 50-59, and greater than or equal to 60 yr, respectively. Corresponding D allele frequencies were 0.52, 0.46, and 0.40 in the respective age groups of HTs, compared with 0.61 in NTs (by chi(2)-analysis, P = 0.1, 0.047, and 0.0006, respectively). In HTs aged greater than or equal to 60, DD frequency was only 14% of expected. Plasma ACE activity tracked similarly with IID genotype in HTs (P = 0.027; n = 35) as in NTs (P = 0.0001; n = 94) and Michaelis constant was identical for DD and II. Neither blood pressure, body mass index, nor sex bore any relationship with I/D genotype, In conclusion, in a group of severely HT patients not selected for cardiac pathology, there appeared to be a marked, selective decrease, in subgroups of increasing age, in frequency of the ACE DD genotype. One possibility suggested by this data might be that DD increases risk of premature death, at least in HTs who have two HT parents.
引用
收藏
页码:1085 / 1089
页数:5
相关论文
共 50 条
  • [1] Cardiovascular protection by angiotensin-converting enzyme inhibition
    Ferrari, Roberto
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2009, 11 (0E) : E1 - E3
  • [2] Interaction Between Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Angiotensin-Converting Enzyme Inhibition on Survival in Hemodialyzed Patients
    Kiss, Istvan
    Ambrus, Csaba
    Kulcsar, Imre
    Szegedi, Janos
    Kerkovits, Lorant
    Tisler, Andras
    Kiss, Zoltan
    MEDICINE, 2014, 93 (28) : e315
  • [3] Angiotensin-converting enzyme gene (ACE) polymorphisms are associated with dysregulation of biochemical parameters in hypertensive patients
    da Agostini, Livia
    Cunha, Warlley R.
    Silva, Nayara N. T.
    Melo, Andre S.
    Moreira, Luciana B.
    Almeida, Tamires C.
    Belo, Vanessa A.
    Coura-Vital, Wendel
    Teixeira, Luiz Fernando de M.
    Lima, Angelica A.
    da Silva, Glenda Nicioli
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (02) : 1487 - 1497
  • [4] NQO1 activation regulates angiotensin-converting enzyme shedding in spontaneously hypertensive rats
    Kim, Yong-Hoon
    Hwang, Jung Hwan
    Kim, Kyung-Shim
    Noh, Jung-Ran
    Gang, Gil-Tae
    Kim, Sang-Woo
    Jang, Seung Pil
    Lee, Sang-Ju
    Her, Sung-Ho
    Jeong, Kyeong-Hoon
    Kwak, Tae Hwan
    Park, Woo Jin
    Balyasnikova, Irina V.
    Shong, Minho
    Lee, Chul-Ho
    CARDIOVASCULAR RESEARCH, 2013, 99 (04) : 743 - 750
  • [5] Angiotensin-converting enzyme inhibition by perindopril in cardiovascular disease
    Simoons, Maarten L.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2009, 11 (0E) : E4 - E8
  • [6] Angiotensin-converting enzyme gene polymorphism and cardiovascular disease
    Butler, R
    Morris, AD
    Struthers, AD
    CLINICAL SCIENCE, 1997, 93 (05) : 391 - 400
  • [7] Value of Pleiotropic Effects of Angiotensin-Converting Enzyme Inhibitors
    Zagidullin, N. Sh.
    Valeeva, K. F.
    Gassanov, F.
    Zagidullin, Sh. Z.
    KARDIOLOGIYA, 2010, 50 (11) : 55 - 60
  • [8] Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications
    Ahmed, A
    Kiefe, CI
    Allman, RM
    Sims, RV
    DeLong, JF
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2002, 50 (10) : 1659 - 1666
  • [9] Angiotensin-converting enzyme polymorphism in patients with terminal renal failure
    Schmidt, A
    Kiener, HP
    Barnas, U
    Arias, I
    Illievich, A
    Auinger, M
    Graninger, W
    Kaider, A
    Mayer, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (02): : 314 - 317
  • [10] Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril
    Ferrari, Roberto
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2005, 3 (01) : 15 - 29